Postherpetic Neuralgia

Pain·MeSH: Neuralgia, Postherpetic

4 drugs in development·4 companies·0 clinical trials

Drug Pipeline by Phase

Phase 2(1)

Drug	Company
amiket	IMMUNE PHARMACEUTICALS INC (IMNP)

Preclinical(2)

Drug	Company
gtx-101	Grace Therapeutics, Inc. (GRCE)
prtt-200	PROTECT PHARMACEUTICAL CORP (PRTT)

Phase 4(1)

Drug	Company
IncobotulinumtoxinA	Revance Therapeutics, Inc. (RVNC)

Full trial data, competitive analysis, and AI-powered pipeline tracking.